180 related articles for article (PubMed ID: 29317832)
1. Upregulated LAMB3 increases proliferation and metastasis in thyroid cancer.
Wang Y; Jin Y; Bhandari A; Yao Z; Yang F; Pan Y; Zheng Z; Lv S; Wang O
Onco Targets Ther; 2018; 11():37-46. PubMed ID: 29317832
[TBL] [Abstract][Full Text] [Related]
2. The lncRNA UNC5B-AS1 promotes proliferation, migration, and invasion in papillary thyroid cancer cell lines.
Wang Y; Bhandari A; Niu J; Yang F; Xia E; Yao Z; Jin Y; Zheng Z; Lv S; Wang O
Hum Cell; 2019 Jul; 32(3):334-342. PubMed ID: 30805847
[TBL] [Abstract][Full Text] [Related]
3. CITED1 gene promotes proliferation, migration and invasion in papillary thyroid cancer.
Xia E; Wang Y; Bhandari A; Niu J; Yang F; Yao Z; Wang O
Oncol Lett; 2018 Jul; 16(1):105-112. PubMed ID: 29928391
[TBL] [Abstract][Full Text] [Related]
4. MFAP2 is a Potential Diagnostic and Prognostic Biomarker That Correlates with the Progression of Papillary Thyroid Cancer.
Dong SY; Chen H; Lin LZ; Jin L; Chen DX; Wang OC; Ye ZQ
Cancer Manag Res; 2020; 12():12557-12567. PubMed ID: 33324100
[TBL] [Abstract][Full Text] [Related]
5. ZCCHC12, a novel oncogene in papillary thyroid cancer.
Wang O; Zheng Z; Wang Q; Jin Y; Jin W; Wang Y; Chen E; Zhang X
J Cancer Res Clin Oncol; 2017 Sep; 143(9):1679-1686. PubMed ID: 28424903
[TBL] [Abstract][Full Text] [Related]
6. Scavenger receptor class A, member 5 is associated with thyroid cancer cell lines progression via epithelial-mesenchymal transition.
Zheng C; Xia EJ; Quan RD; Bhandari A; Wang OC; Hao RT
Cell Biochem Funct; 2020 Mar; 38(2):158-166. PubMed ID: 31989658
[TBL] [Abstract][Full Text] [Related]
7.
Xu M; Wen J; Xu Q; Li H; Lin B; Bhandari A; Qu J
Curr Cancer Drug Targets; 2024; 24(2):220-229. PubMed ID: 36089788
[TBL] [Abstract][Full Text] [Related]
8. GABRB2 plays an important role in the lymph node metastasis of papillary thyroid cancer.
Jin Y; Jin W; Zheng Z; Chen E; Wang Q; Wang Y; Wang O; Zhang X
Biochem Biophys Res Commun; 2017 Oct; 492(3):323-330. PubMed ID: 28859983
[TBL] [Abstract][Full Text] [Related]
9. High Diagnostic Accuracy Based on CLDN10, HMGA2, and LAMB3 Transcripts in Papillary Thyroid Carcinoma.
Barros-Filho MC; Marchi FA; Pinto CA; Rogatto SR; Kowalski LP
J Clin Endocrinol Metab; 2015 Jun; 100(6):E890-9. PubMed ID: 25867809
[TBL] [Abstract][Full Text] [Related]
10. The expression and function of long noncoding RNA lncRNA-ATB in papillary thyroid cancer.
Fu XM; Guo W; Li N; Liu HZ; Liu J; Qiu SQ; Zhang Q; Wang LC; Li F; Li CL
Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3239-3246. PubMed ID: 28770959
[TBL] [Abstract][Full Text] [Related]
11. Proto-oncogene RTL4 promotes tumorigenesis and invasiveness of papillary thyroid cancer.
Kong L; Bhandari A; Zhang X; Wang O
Am J Transl Res; 2020; 12(6):3023-3032. PubMed ID: 32655827
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of CDH16 in Papillary Thyroid Cancer and Its Potential Molecular Mechanism Analysed by qRT-PCR, TCGA and in silico Analysis.
Li P; Wu Q; Sun Y; Pan X; Han Y; Ye B; Zhang Y; Dong J; Zheng Z
Cancer Manag Res; 2019; 11():10719-10729. PubMed ID: 31920382
[TBL] [Abstract][Full Text] [Related]
13. LncRNAs SNHG12 and LINC00152 were associated with progression of patients with papillary thyroid carcinoma.
Liu J; Tang X; Lv J; Peng X; Zhang K; Li C; Liu J; Wang G; Li Z
Future Oncol; 2019 Dec; 15(36):4167-4179. PubMed ID: 31773972
[No Abstract] [Full Text] [Related]
14. ALDH5A1 acts as a tumour promoter and has a prognostic impact in papillary thyroid carcinoma.
Deng XY; Gan XX; Feng JH; Cai WS; Wang XQ; Shen L; Luo HT; Chen Z; Guo M; Cao J; Shen F; Xu B
Cell Biochem Funct; 2021 Mar; 39(2):317-325. PubMed ID: 32881051
[TBL] [Abstract][Full Text] [Related]
15. Clinical Study of Ultrasonographic Risk Factors for Central Lymph Node Metastasis of Papillary Thyroid Carcinoma.
Guang Y; He W; Zhang W; Zhang H; Zhang Y; Wan F
Front Endocrinol (Lausanne); 2021; 12():791970. PubMed ID: 34917039
[TBL] [Abstract][Full Text] [Related]
16. SYT12 is a novel oncogene that promotes thyroid carcinoma progression and metastasis.
Jin L; Zheng D; Chen D; Xia E; Guan Y; Wen J; Bhandari A; Wang O
J Cancer; 2021; 12(22):6851-6860. PubMed ID: 34659573
[No Abstract] [Full Text] [Related]
17. MicroRNA-451 as a prognostic marker for diagnosis and lymph node metastasis of papillary thyroid carcinoma.
Zhang M; Wu W; Gao M; Fei Z
Cancer Biomark; 2017 Jul; 19(4):437-445. PubMed ID: 28582849
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of long non-coding RNA NR_036575.1 contributes to the proliferation and migration of papillary thyroid cancer.
Sun W; Lan X; Wang Z; Dong W; He L; Zhang T; Zhang H
Med Oncol; 2016 Sep; 33(9):102. PubMed ID: 27510368
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA ABHD11-AS1 functions as a competing endogenous RNA to regulate papillary thyroid cancer progression by miR-199a-5p/SLC1A5 axis.
Zhuang X; Tong H; Ding Y; Wu L; Cai J; Si Y; Zhang H; Shen M
Cell Death Dis; 2019 Aug; 10(8):620. PubMed ID: 31409775
[TBL] [Abstract][Full Text] [Related]
20. LRP4 promotes proliferation, migration, and invasion in papillary thyroid cancer.
Zhou X; Xia E; Bhandari A; Zheng C; Xiang J; Guan Y; Zhang X
Biochem Biophys Res Commun; 2018 Sep; 503(1):257-263. PubMed ID: 29885843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
